These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Next generation MUT-MAP, a high-sensitivity high-throughput microfluidics chip-based mutation analysis panel. Schleifman EB; Tam R; Patel R; Tsan A; Sumiyoshi T; Fu L; Desai R; Schoenbrunner N; Myers TW; Bauer K; Smith E; Raja R PLoS One; 2014; 9(3):e90761. PubMed ID: 24658394 [TBL] [Abstract][Full Text] [Related]
27. Reporting tumor molecular heterogeneity in histopathological diagnosis. Mafficini A; Amato E; Fassan M; Simbolo M; Antonello D; Vicentini C; Scardoni M; Bersani S; Gottardi M; Rusev B; Malpeli G; Corbo V; Barbi S; Sikora KO; Lawlor RT; Tortora G; Scarpa A PLoS One; 2014; 9(8):e104979. PubMed ID: 25127237 [TBL] [Abstract][Full Text] [Related]
28. Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary. Bochtler T; Reiling A; Endris V; Hielscher T; Volckmar AL; Neumann O; Kirchner M; Budczies J; Heukamp LC; Leichsenring J; Allgäuer M; Kazdal D; Löffler H; Weichert W; Schirmacher P; Stenzinger A; Krämer A Int J Cancer; 2020 Jun; 146(11):3053-3064. PubMed ID: 31970771 [TBL] [Abstract][Full Text] [Related]
29. Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer. Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S Anticancer Res; 2018 Oct; 38(10):5627-5634. PubMed ID: 30275180 [TBL] [Abstract][Full Text] [Related]
30. Klempner SJ; Madison R; Pujara V; Ross JS; Miller VA; Ali SM; Schrock AB; Kim ST; Maron SB; Dayyani F; Catenacci DVT; Lee J; Chao J Oncologist; 2019 Nov; 24(11):1462-1468. PubMed ID: 31249137 [TBL] [Abstract][Full Text] [Related]
31. Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients. Dong Z; Kong L; Wan Z; Zhu F; Zhong M; Lv Y; Zhao P; Shi H Sci Rep; 2019 Nov; 9(1):16894. PubMed ID: 31729406 [TBL] [Abstract][Full Text] [Related]
32. Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study. Serizawa M; Koh Y; Kenmotsu H; Isaka M; Murakami H; Akamatsu H; Mori K; Abe M; Hayashi I; Taira T; Maniwa T; Takahashi T; Endo M; Nakajima T; Ohde Y; Yamamoto N Cancer; 2014 May; 120(10):1471-81. PubMed ID: 24700479 [TBL] [Abstract][Full Text] [Related]
33. Genomic profiling in a homogeneous molecular subtype of non-small cell lung cancer: An effort to explore new drug targets. Veldore VH; Patil S; Satheesh CT; Shashidhara HP; Tejaswi R; Prabhudesai SA; Krishnamoorthy N; Hazarika D; Naik R; Rao RM; Ajai Kumar BS Indian J Cancer; 2015; 52(2):243-8. PubMed ID: 26853422 [TBL] [Abstract][Full Text] [Related]
34. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing. Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406 [TBL] [Abstract][Full Text] [Related]
35. High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer. Korphaisarn K; Pongpaibul A; Roothumnong E; Pongsuktavorn K; Thamlikitkul L; Anekpuritanang T; Poungvarin N; Thongnoppakhun W; Pithukpakorn M Asian Pac J Cancer Prev; 2019 Aug; 20(8):2319-2326. PubMed ID: 31450901 [TBL] [Abstract][Full Text] [Related]
36. Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing. Zhang L; Chen L; Sah S; Latham GJ; Patel R; Song Q; Koeppen H; Tam R; Schleifman E; Mashhedi H; Chalasani S; Fu L; Sumiyoshi T; Raja R; Forrest W; Hampton GM; Lackner MR; Hegde P; Jia S Oncologist; 2014 Apr; 19(4):336-43. PubMed ID: 24664487 [TBL] [Abstract][Full Text] [Related]
37. Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas. Cortot AB; Younes M; Martel-Planche G; Guibert B; Isaac S; Souquet PJ; Commo F; Girard P; Fouret P; Brambilla E; Hainaut P; Soria JC Clin Lung Cancer; 2014 Mar; 15(2):124-30. PubMed ID: 24169260 [TBL] [Abstract][Full Text] [Related]
38. FNA smears of pancreatic ductal adenocarcinoma are superior to formalin-fixed paraffin-embedded tissue as a source of DNA: Comparison of targeted KRAS amplification and genotyping in matched preresection and postresection samples. Hartley CP; Mahajan AM; Selvaggi SM; Rehrauer WM Cancer Cytopathol; 2017 Nov; 125(11):838-847. PubMed ID: 29024530 [TBL] [Abstract][Full Text] [Related]
39. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR. Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035 [TBL] [Abstract][Full Text] [Related]
40. Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma. Baum JE; Zhang P; Hoda RS; Geraghty B; Rennert H; Narula N; Fernandes HD Cancer Cytopathol; 2017 Jun; 125(6):398-406. PubMed ID: 28272845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]